TCR2 Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
JOVAN-EMBIRICOS MORANA 10 percent owner
 Common Stock 29,128 N/A N/A
Sale
JOVAN-EMBIRICOS MORANA 10 percent owner
 Common Stock 3 N/A N/A
Sale
JOVAN-EMBIRICOS MORANA 10 percent owner
 Common Stock 100 N/A N/A
Sale
JOVAN-EMBIRICOS MORANA 10 percent owner
 Common Stock 500 N/A N/A
Purchase
GADICKE ANSBERT director, 10 percent owner
 Common Stock 1,373,333 N/A N/A
Purchase
JOVAN-EMBIRICOS MORANA 10 percent owner
 Common Stock 666,667 N/A N/A
Purchase
MPM BIOVENTURES 2014, L.P. 10 percent owner
 Common Stock 706,666 N/A N/A
Purchase
UBS ONCOLOGY IMPACT FUND L.P. 10 percent owner
 Common Stock 666,667 N/A N/A
Purchase
MPM SUNSTATES FUND, L.P. 10 percent owner
 Common Stock 706,666 N/A N/A
Purchase
UPNORTH INVESTMENT LTD 10 percent owner
 Common Stock 200,000 N/A N/A

Showing 100 to 110 of 110 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: